Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 15 Rectal Neoplasms 14 Colonic Neoplasms 14 Stomach Neoplasms 10 Ovarian Neoplasms 7 Carcinoma, Hepatocellular 5 Gastrointestinal Stromal Tumors 4 Carcinoma, Renal Cell 4 Peritoneal Neoplasms 3 Pancreatic Neoplasms 3 Liver Neoplasms 3 Neoplastic Cells, Circulating 2 Neoplasms 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neuroendocrine Tumors 1 Ovarian Cysts 1 Obesity, Morbid 1 Neoplasm Metastasis 1

Interventions

Misoprostol 5 Uterine Myomectomy 3 Saline Solution 3 relugolix 2 dienogest 2 carbetocin 2 Uterine Artery Embolization 2 Tranexamic Acid 2 Tourniquets 2 Lidocaine 2 Leuprolide 2 Ascorbic Acid 2 ulipristal 1 telapristone acetate 1 ramosetron 1 pirfenidone 1 estradiol, norethindrone drug combination 1 Vasopressins 1 Triptorelin Pamoate 1 Tablets 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1 Oxytocin 1 Nuclear Receptor Subfamily 4, Group A, Member 2 1 Morcellation 1 Methylergonovine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myofibroma × Laparoscopy × Clear all

NCT06067971 2025-09-12

ENDORA2

University Hospital, Clermont-Ferrand

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡